Cargando…

Safety of aromatase inhibitors in the adjuvant setting

Detalles Bibliográficos
Autor principal: Perez, Edith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969805/
http://dx.doi.org/10.1007/s10549-007-9854-7
_version_ 1782445846679257088
author Perez, Edith A.
author_facet Perez, Edith A.
author_sort Perez, Edith A.
collection PubMed
description
format Online
Article
Text
id pubmed-4969805
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-49698052016-08-17 Safety of aromatase inhibitors in the adjuvant setting Perez, Edith A. Breast Cancer Res Treat Erratum Springer US 2007-12-13 2008 /pmc/articles/PMC4969805/ http://dx.doi.org/10.1007/s10549-007-9854-7 Text en © Springer Science+Business Media, LLC. 2007
spellingShingle Erratum
Perez, Edith A.
Safety of aromatase inhibitors in the adjuvant setting
title Safety of aromatase inhibitors in the adjuvant setting
title_full Safety of aromatase inhibitors in the adjuvant setting
title_fullStr Safety of aromatase inhibitors in the adjuvant setting
title_full_unstemmed Safety of aromatase inhibitors in the adjuvant setting
title_short Safety of aromatase inhibitors in the adjuvant setting
title_sort safety of aromatase inhibitors in the adjuvant setting
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969805/
http://dx.doi.org/10.1007/s10549-007-9854-7
work_keys_str_mv AT perezeditha safetyofaromataseinhibitorsintheadjuvantsetting